Today’s acquisition of ArisGlobal marks a major step forward in executing that vision. By combining our leadership in scientific modeling and simulation with their expertise in safety and regulatory intelligence, we are creating the industry’s first AI platform that unifies real-world evidence with virtual evidence. This will help customers accelerate innovation, strengthen compliance, and bring more effective therapies to patients faster. Together, we are uniquely positioned to lead the digital transformation of Life Sciences. <\/p>\n
As AI is becoming the new interface to industry, our 3DEXPERIENCE platform is evolving into an agentic platform, where Virtual Companions work alongside engineers, designers, scientists and manufacturers to accelerate decision-making and execution. Built on decades of scientific knowledge, industry expertise and enterprise data and simulation, they deliver trusted and actionable intelligence while preserving the scientific accuracy, governance and workflow continuity our customers depend on. By bringing together modeling, simulation, enterprise data and AI, we are building the next generation of industrial co-creation platform, helping customers transform their businesses faster, more sustainably and with greater confidence.” <\/p>\n
Dassault Syst\u00e8mes’ Chief Financial Officer Commentary <\/p>\n
(operating margin, operating cash flow and diluted EPS (“EPS”) growth rates in constant currencies, data on a non-IFRS basis, operating cash flow in IFRS,
data for the second quarter, unless otherwise noted) <\/p>\n
Rouven Bergmann, Dassault Syst\u00e8mes’ Chief Financial Officer, commented: <\/p>\n
“Good Q2 performance keeps us firmly on track for the full year. We’re not just executing on our objectives, we are transforming the company, launching new categories of AI solutions, all while improving cash flow and margin. This is growth and discipline together. <\/p>\n
Our key growth drivers accelerated – 3DEXPERIENCE and Cloud revenue up 14% – as clients scale the transformation of their operations to capture AI\u2011powered Virtual Twin opportunities. <\/p>\n
Our business model transition continues to progress with ARR increasing 6%3 driven by double-digit growth subscription ARR and Life Sciences contribution beginning to ramp. <\/p>\n
Operationally, we expanded our operating margin to 30.0%, reflecting focused productivity gains, and EPS was up 8%. In the first half, we generated \u20ac1.24 billion in operating cash flow up 11%, improving our cash conversion compared to last year. <\/p>\n
Turning to capital allocation, the acquisition of ArisGlobal represents a rare strategic opportunity to expand our leadership in Life Sciences, while preserving the necessary capacity for future investments. We expect the transaction to be both revenue growth and EPS accretive in the first year post-close. <\/p>\n
As we look ahead, we confirm our 2026 outlook.” <\/p>\n
Financial Summary <\/p>\n
In millions of Euros,
except per share data and percentages<\/p>\n
IFRS <\/p>\n
IFRS <\/p>\n
Q2 2026 <\/p>\n
Q2 2025 <\/p>\n
Change <\/p>\n
Change in constant currencies <\/p>\n
YTD 2026 <\/p>\n
YTD 2025 <\/p>\n
Change <\/p>\n
Change in constant currencies <\/p>\n
Total Revenue <\/p>\n
1,555.8 <\/p>\n
1,521.6 <\/p>\n
2% <\/p>\n
4% <\/p>\n
3,065.0 <\/p>\n
3,094.6 <\/p>\n
(1)% <\/p>\n
4% <\/p>\n
Software Revenue <\/p>\n
1,400.6 <\/p>\n
1,372.7 <\/p>\n
2% <\/p>\n
4% <\/p>\n
2,775.5 <\/p>\n
2,805.4 <\/p>\n
(1)% <\/p>\n
3% <\/p>\n
Operating Margin <\/p>\n
23.0% <\/p>\n
15.9% <\/p>\n
+7.1pts <\/p>\n
23.0% <\/p>\n
17.6% <\/p>\n
+5.4pts <\/p>\n
Diluted EPS <\/p>\n
0.22 <\/p>\n
0.17 <\/p>\n
33% <\/p>\n
0.44 <\/p>\n
0.37 <\/p>\n
22% <\/p>\n
In millions of Euros,
except per share data and percentages<\/p>\n
Non-IFRS <\/p>\n
Non-IFRS <\/p>\n
Q2 2026 <\/p>\n
Q2 2025 <\/p>\n
Change <\/p>\n
Change in constant currencies <\/p>\n
YTD 2026 <\/p>\n
YTD 2025 <\/p>\n
Change <\/p>\n
Change in constant currencies <\/p>\n
Total Revenue <\/p>\n
1,555.8 <\/p>\n
1,523.2 <\/p>\n
2% <\/p>\n
4% <\/p>\n
3,065.5 <\/p>\n
3,096.2 <\/p>\n
(1%) <\/p>\n
3% <\/p>\n
Software Revenue <\/p>\n
1,400.7 <\/p>\n
1,374.2 <\/p>\n
2% <\/p>\n
4% <\/p>\n
2,776.0 <\/p>\n
2,807.0 <\/p>\n
(1%) <\/p>\n
3% <\/p>\n
Operating Margin <\/p>\n
30.0% <\/p>\n
29.3% <\/p>\n
+0.7pt <\/p>\n
30.1% <\/p>\n
30.1% <\/p>\n
+0.0pt <\/p>\n
Diluted EPS <\/p>\n
0.31 <\/p>\n
0.30 <\/p>\n
5% <\/p>\n
8% <\/p>\n
0.61 <\/p>\n
0.61 <\/p>\n
(1)% <\/p>\n
6% <\/p>\n
Second Quarter 2026 Versus 2025 Financial Comparisons <\/p>\n
(unaudited, IFRS and non-IFRS unless otherwise noted,
all revenue growth rates in constant currencies) <\/p>\n
Total Revenue: Total revenue in the second quarter grew 4% to \u20ac1.56 billion, and software revenue rose 4% to \u20ac1.40 billion. Subscription & support revenue rose 5%; recurring revenue represented 81% of software revenue. Licenses and other software revenue were up 1% to \u20ac272 million. Services revenue increased 6% to \u20ac155 million. <\/p>\n
ARR: In the second quarter, ARR grew 6% year-over-year to reach \u20ac4.44 billion on a constant currency basis4, reflecting the continued strengthening of our business model.<\/p>\n
Software Revenue by Geography: The Americas revenue increased 5%, driven by Manufacturing Industries, in particular Home & Lifestyle, High-Tech and Industrial Equipment. The Americas represented 37% of software revenue. <\/p>\n
Europe (38% of software revenue) was flat after strong growth in Q1, on weakness in the Automotive sector in Mainland Europe, partially offset by double-digit growth in Northern Europe. Energy, Industrial Equipment and Aerospace & Defense showed healthy growth. <\/p>\n
Asia (25% of software revenue) was up 8%, delivering an excellent quarter particularly in India, Korea and Japan. In China, revenue was lower, with pipeline improving. Transportation & Mobility and High-Tech saw a strong momentum. <\/p>\n
Mainstream Innovation software revenue increased by 8% to \u20ac380 million. SOLIDWORKS continued its broad-based momentum across geographies, with unit growth up double digits. CENTRIC delivered an excellent performance in Q2, highlighted by several significant competitive wins. <\/p>\n
Life Sciences & Healthcare software revenue was down 4% to \u20ac252 million. MEDIDATA revenue decreased by 3%. MEDIDATA benefited from solid bookings in the first half, driving positive growth in ARR as of Q2.<\/p>\n
Software Revenue by Industry: Transportation & Mobility, Aerospace & Defense, Home & Lifestyle and Industrial Equipment were the main contributors to growth this quarter. <\/p>\n
Key Strategic Drivers: 3DEXPERIENCE software revenue increased 14% and represented 43% of 3DEXPERIENCE Eligible software revenue, compared to 41% last year. Cloud software revenue grew 14%, representing 28% of software revenue during the period. <\/p>\n
This performance underscores the good traction with customers adopting and expanding to the 3DEXPERIENCE platform, as they look to transform their operations to capture AI-powered Virtual Twin opportunities in the future. <\/p>\n
Operating Income and Margin: IFRS operating income increased 48% to \u20ac358 million, as reported, with lower share-based compensation and related social charges. Non-IFRS operating income increased 5% to \u20ac467 million, as reported, and increased 7% in constant currencies. The IFRS operating margin stood at 23.0% compared to 15.9% in the second quarter of 2025. The non-IFRS operating margin totaled 30.0%, versus 29.3% in the same period of last year.<\/p>\n
Diluted Earnings per Share: IFRS diluted EPS was \u20ac0.22, increasing 33% as reported. Non-IFRS diluted EPS grew to \u20ac0.31, up 5% as reported and up 8% in constant currencies.<\/p>\n
First Half 2026 Versus 2025 Financial Comparisons <\/p>\n
(unaudited, IFRS and non-IFRS unless otherwise noted,
all revenue growth rates in constant currencies) <\/p>\n
Total Revenue: In the first half, total revenue grew 3% in non-IFRS and 4% in IFRS to \u20ac3.07 billion. Software revenue increased 3% to \u20ac2.78 billion. Subscription and support revenue rose 3% to \u20ac2.30 billion; recurring revenue represented 83% of total software revenue. Licenses and other software revenue increased 4% to \u20ac472 million. Services revenue was up 5% to \u20ac290 million.<\/p>\n
Software Revenue by Geography: The Americas grew by 2%, Europe increased by 3% and Asia was up 6%, representing respectively 39%, 38% and 23% of software revenue. <\/p>\n
Software Revenue by Product Line: <\/p>\n
Life Sciences software revenue decreased 3% to \u20ac511 million, representing 18% of software revenue. <\/p>\n
Mainstream Innovation software revenue increased by 11% to \u20ac747 million. Mainstream Innovation represented 27% of software revenue. <\/p>\n
Software Revenue by Industry: Home & Lifestyle, Transportation & Mobility and Industrial Equipment were among the strongest contributors to growth.<\/p>\n
Key Strategic Drivers: 3DEXPERIENCE software revenue increased by 10%, representing 42% of 3DEXPERIENCE Eligible software revenue. Cloud software revenue grew 11% in non-IFRS, and represented 27% of software revenue. 3DEXPERIENCE Cloud software revenue increased 46% in constant currencies. <\/p>\n
Operating Income and Margin: IFRS operating income was up 29%, to \u20ac706 million, as reported. Non-IFRS operating income decreased 1% to \u20ac924 million, as reported, and increased 5% in constant currencies. IFRS operating margin totaled 23.0% compared to 17.6% for the same period in 2025, with lower share-based compensation and related social charges. Non-IFRS operating margin stood at 30.1% in the first half of 2026, stable compared to the same period last year. <\/p>\n
Diluted Earnings per Share: IFRS diluted EPS was \u20ac0.44, an increase of 22% as reported. Non-IFRS diluted EPS declined 1% to \u20ac0.61, as reported, and increased by 6% in constant currencies. <\/p>\n
Cash Flow from Operations (IFRS): In the first half, cash flow from operations was up 11% in constant currencies to \u20ac1.24 billion, compared to \u20ac1.15 billion last year. Cash flow from operations was supported by strong cash conversion, and was principally used for dividend payments of \u20ac357 million and debt repayment of \u20ac217 million.<\/p>\n
Balance Sheet (IFRS): Dassault Syst\u00e8mes’ net financial position totaled \u20ac2.28 billion as of June 30, 2026, an increase of \u20ac0.75 billion, compared to \u20ac1.53 billion for the year ended December 31, 2025. Cash and cash equivalents totaled \u20ac5.66 billion in the first half, with Dassault Syst\u00e8mes issuing a new bond on June 2026 for \u20ac1.00 billion.<\/p>\n
Financial Objectives for 2026 <\/p>\n
Dassault Syst\u00e8mes’ third quarter and 2026 financial objectives presented below are given on a non-IFRS basis and reflect the principal 2026 currency exchange rate assumptions for the US dollar and Japanese yen as well as the potential impact from additional non-Euro currencies: <\/p>\n
Q3 2026 <\/p>\n
FY 2026 <\/p>\n
Total Revenue (billion) <\/p>\n
\u20ac1.497 – \u20ac1.537 <\/p>\n
\u20ac6.296 – \u20ac6.416 <\/p>\n
Growth <\/p>\n
2 – 5% <\/p>\n
1 – 3% <\/p>\n
Growth ex FX <\/p>\n
3 – 5% <\/p>\n
3 – 5% <\/p>\n
Software revenue growth * <\/p>\n
3 – 5% <\/p>\n
3 – 5% <\/p>\n
Services revenue growth * <\/p>\n
4 – 8% <\/p>\n
2 – 6% <\/p>\n
Operating Margin <\/p>\n
31.0% – 31.1% <\/p>\n
32.2% – 32.6% <\/p>\n
Diluted EPS <\/p>\n
\u20ac0.30 – \u20ac0.31 <\/p>\n
\u20ac1.30 – \u20ac1.34 <\/p>\n
Growth <\/p>\n
4 – 7% <\/p>\n
(1) – 2% <\/p>\n
Growth ex FX <\/p>\n
4 – 7% <\/p>\n
3 – 6% <\/p>\n
US dollar <\/p>\n
$1.18 per Euro <\/p>\n
$1.17 per Euro <\/p>\n
Japanese yen (before hedging) <\/p>\n
JPY 170.0 per Euro <\/p>\n
JPY 177.1 per Euro <\/p>\n
* Growth in Constant Currencies <\/p>\n
These objectives are prepared and communicated only on a non-IFRS basis and are subject to the cautionary statement set forth below. <\/p>\n
The 2026 non-IFRS financial objectives set forth above do not take into account the following accounting elements below and are estimated based upon the 2026 principal currency exchange rates above: contract liabilities write-downs was not significant; share-based compensation expenses, including related social charges, estimated at approximately \u20ac115 million (these estimates do not include any new stock option or share grants issued after June 30, 2026); amortization of acquired intangibles and of tangibles reevaluation, estimated at approximately \u20ac315 million, largely impacted by the acquisition of MEDIDATA; and lease incentives of acquired companies at approximately \u20ac1 million. <\/p>\n
The above objectives also do not include any impact from other operating income and expenses, net principally comprised of acquisition, integration, IT transformation projects and restructuring expenses, and impairment of goodwill and acquired intangible assets; from one-time items included in financial revenue; from one-time tax effects; and from the income tax effects of these non-IFRS adjustments. Finally, these estimates do not include any new acquisitions or restructuring completed after June 30, 2026. <\/p>\n
Corporate Announcements <\/p>\n
July 23, 2026: Dassault Syst\u00e8mes to acquire ArisGlobal, creating a unified AI intelligence platform for the Life Sciences industry connecting molecule, patient and real-world outcomes<\/a> and<\/p>\n July 23, 2026 : Dassault Syst\u00e8mes Expands the <\/a>3D<\/a>EXPERIENCE AI-Native Agentic Platform with New Virtual Companion Skills to Co-Engineer with Humans<\/a><\/p>\n July 23, 2026 : MEDIDATA Launches Medidata Plus, an AI Native Foundation Built to Scale Clinical Portfolios <\/a><\/p>\n July 23, 2026: Dassault Syst\u00e8mes Sets New SBTi-Validated Net-Zero Target<\/a><\/p>\n June 15, 2026: Dassault Syst\u00e8mes Successfully Issues \u20ac1 Billion In Bonds And Refinances Its Revolving Credit Facility<\/a><\/p>\n June 10, 2026: CENTRIC Confirmed as Dassault Syst\u00e8mes’ PLM Standard for Consumer Goods & Retail<\/a><\/p>\n June 9, 2026: OUTSCALE Strengthens its Sovereign Cloud and AI Foundation for Critical Organizations<\/a><\/p>\n May 28, 2026: MEDIDATA’s Next-Gen AI Imaging Solution Delivers Unprecedented Speed and Precision for Clinical Trials<\/a><\/p>\n April 23, 2026: Worldwide Clinical Trials and MEDIDATA Announce Strategic Partnership to Embed Medidata AI Across the Full Trial Lifecycle, Bolstering Study Execution and Delivery Excellence<\/a><\/p>\n April 21, 2026: OMRON and Dassault Syst\u00e8mes Partner to Revolutionize Manufacturing with Virtual and Real Integration<\/a><\/p>\n April 14, 2026: Groupe Rocher and Dassault Syst\u00e8mes Embark on New Collaboration to Transform Natural Cosmetics Formulation Through Virtual Twin Technology<\/a><\/p>\n Today’s Webcast and Conference Call Information <\/p>\n Today, Thursday, July 23, 2026, Dassault Syst\u00e8mes will host in Paris a webcasted presentation at 9:00 AM London Time \/ 10:00 AM Paris time, and will then host a conference call at 8:30 AM New York time \/ 1:30 PM London time \/ 2:30 PM Paris time. The webcasted presentation and conference calls will be available online by accessing investor.3ds.com. <\/p>\n Additional investor information is available at investor.3ds.com or by calling Dassault Syst\u00e8mes’ Investor Relations at +33.1.61.62.69.24. <\/p>\n Investor Relations Events <\/p>\n Third Quarter 2026 Earnings Release: October 28, 2026 <\/p>\n Capital Markets Day: November 17, 2026 <\/p>\n Fourth Quarter 2026 Earnings Release: February 3, 2027 <\/p>\n First Quarter 2027 Earnings Release: April 28, 2027 <\/p>\n Forward-looking Information <\/p>\n Statements herein that are not historical facts but express expectations or objectives for the future, including but not limited to statements regarding the Group’s non-IFRS financial performance objectives are forward-looking statements. Such forward-looking statements are based on Dassault Syst\u00e8mes management’s current views and assumptions and involve known and unknown risks and uncertainties. Actual results or performances may differ materially from those in such statements due to a range of factors. <\/p>\n The Group’s actual results or performance may be materially negatively affected by numerous risks and uncertainties, as described in the “Risk Factors” section 1.9 of the 2025 Universal Registration Document (‘Document d’enregistrement universel’) filed with the AMF (French Financial Markets Authority) on March 31, 2026, available on the Group’s website www.3ds.com<\/a>. <\/p>\n In particular, please refer to the risk factor “Uncertain Global Environment” in section 1.9.1.1 of the 2025 Universal Registration Document set out below for ease of reference: <\/p>\n “In light of the uncertainties regarding economic, business, social, health and geopolitical conditions at the global level, Dassault Syst\u00e8mes’ revenue, net earnings and cash flows may grow more slowly, whether on an annual or quarterly basis, mainly due to the following factors: <\/p>\n the deployment of Dassault Syst\u00e8mes’ solutions may represent a large portion of a customer’s investments in software technology. Decisions to make such an investment are impacted by the economic environment in which the customers operate. Uncertain global geopolitical, economic and health conditions and the lack of visibility or the lack of financial resources may cause some customers, e.g. within the automotive, aerospace, energy or natural resources industries, to reduce, postpone or cancel their investments, or to reduce or not renew ongoing paid maintenance for their installed base, which impact larger customers’ revenue with their respective sub-contractors; <\/p>\n the geopolitical, economic and monetary situation in certain geographic regions where Dassault Syst\u00e8mes operates could become more volatile and negatively affect Dassault Syst\u00e8mes’ business, and in particular its revenue, for example due to stricter export compliance rules, or the implementation of new customs barriers or controls on the exchange of goods and services; <\/p>\n continued inflationary pressure or volatility on raw materials, computer hardware and energy prices could also slow down Dassault Syst\u00e8mes’ diversification efforts in new industries or negatively affect its financial health; and <\/p>\n the sales cycles of Dassault Syst\u00e8mes’ products, which are relatively long due to the strategic nature of such investments for customers, could further lengthen. <\/p>\n Tensions, particularly geopolitical, economic, financial or customs tensions, and the occurrence of crises could adversely impact the financial situation or financing and supply capabilities of Dassault Syst\u00e8mes’ existing and potential customers, commercial and technology partners, some of whom may be forced to temporarily close sites or to cease operations. Certain crises \u2013 health and geopolitical crises in particular \u2013 could also have consequences both for the health and safety of Dassault Syst\u00e8mes’ employees and for the Company. A deteriorating economic environment, such as deflationary pressure in Asia, could generate increased price pressure and affect the collection of receivables, which would negatively affect Dassault Syst\u00e8mes’ revenue, financial performance and market position. Dassault Syst\u00e8mes makes every effort to take into consideration this uncertain outlook. Dassault Syst\u00e8mes’ business results, however, may not develop as anticipated. Furthermore, due to factors affecting sales of Dassault Syst\u00e8mes’ products and services, there may be a substantial time lag between an improvement in global economic and business conditions and an upswing in the Company’s business results.” <\/p>\n In preparing such forward-looking statements, the Group has in particular assumed an average US dollar to euro exchange rate of US$1.18 per \u20ac1.00 as well as an average Japanese yen to euro exchange rate of JPY170.0 to \u20ac1.00, before hedging for the third quarter 2026. The Group has assumed an average US dollar to euro exchange rate of US$1.17 per \u20ac1.00 as well as an average Japanese yen to euro exchange rate of JPY177.1 to \u20ac1.00, before hedging for the full year 2026. However, currency values fluctuate, and the Group’s results may be significantly affected by changes in exchange rates. <\/p>\n Non-IFRS Financial Information <\/p>\n Readers are cautioned that the supplemental non-IFRS financial information presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered in isolation from or as a substitute for IFRS measurements. The supplemental non-IFRS financial information should be read only in conjunction with the Company’s consolidated financial statements prepared in accordance with IFRS. Furthermore, the Group’s supplemental non-IFRS financial information may not be comparable to similarly titled “non-IFRS” measures used by other companies. Specific limitations for individual non-IFRS measures are set forth in the Company’s 2025 Universal Registration Document filed with the AMF on March 31, 2026. <\/p>\n In the tables accompanying this press release the Group sets forth its supplemental non-IFRS figures for revenue, operating income, operating margin, net income and diluted earnings per share, which exclude the effect of adjusting the carrying value of acquired companies’ deferred revenue, share-based compensation expense and related social charges, the amortization of acquired intangible assets and of tangibles reevaluation, certain other operating income and expense, net, including impairment of goodwill and acquired intangibles, acquisition, integration, IT transformation projects and restructuring expenses, the effect of adjusting lease incentives of acquired companies, certain one-time items included in financial revenue and other, net, and the income tax effect of the non-IFRS adjustments and certain one-time tax effects. The tables also set forth the most comparable IFRS financial measure and reconciliations of this information with non-IFRS information. <\/p>\n ABOUT DASSAULT SYST\u00c8MES <\/p>\n Dassault Syst\u00e8mes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. Through the 3DEXPERIENCE platform, AI-powered, science-based virtual twins help 390,000 customers of all sizes, in all industries, collaborate, imagine and create sustainable innovations that drive meaningful impact. Dassault Syst\u00e8mes Investor Relations Team FTI Consulting <\/p>\n Marie Dumas : +33 1 61 62 70 92 Arnaud de Cheffontaines: +33 1 47 03 69 48 <\/p>\n investors@3ds.com<\/a> Jamie Ricketts : +44 20 3727 1600 <\/p>\n Dassault Syst\u00e8mes Press Contacts <\/p>\n Arnaud Malherbe \/ D\u00e9borah Cobbi <\/p>\n +33 (0)1 61 62 87 73 \/ 70 83 <\/p>\n arnaud.malherbe@3ds.com<\/a> \/ deborah.cobbi@3ds.com<\/a> <\/p>\n \u00a9 Dassault Syst\u00e8mes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DVIA, BIOVIA, CATIA, CENTRIC, DELMIA, ENOVIA, GEOVIA, MEDIDATA, OUTSCALE, SIMULIA, SOLIDWORKS, NETVIBES and 3DEXCITE are commercial trademarks or registered trademarks of Dassault Syst\u00e8mes, a European company (Societas Europaea) incorporated under French law, and registered with the Versaillecompanies registry under number 322 306 440, or its subsidiaries in the United States and\/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Syst\u00e8mes or its subsidiaries trademarks is subject to their express written approval. <\/p>\n APPENDIX TABLE OF CONTENTS <\/p>\n Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures. <\/p>\n Glossary of Definitions <\/p>\n Non-IFRS Financial Information <\/p>\n Acquisitions and Foreign Exchange Impact <\/p>\n Condensed consolidated statements of income <\/p>\n Condensed consolidated balance sheet <\/p>\n Condensed consolidated cash flow statement <\/p>\n IFRS \u2013 non-IFRS reconciliation <\/p>\n DASSAULT SYST\u00c8MES – Glossary of Definitions <\/p>\n Information in Constant Currencies <\/p>\n Dassault Syst\u00e8mes has followed a long-standing policy of measuring its revenue performance and setting its revenue objectives in constant currencies in order to measure in a transparent manner the underlying level of improvement in its total revenue and software revenue by activity, industry, geography and product lines. The Group believes it is helpful to evaluate its growth exclusive of currency impacts, particularly to help understand revenue trends in its business. Therefore, the Group provides percentage increases or decreases in its revenue and expenses (in both IFRS and non-IFRS) to eliminate the effect of changes in currency values, particularly the U.S. dollar and the Japanese yen, relative to the euro. When trend information is expressed “in constant currencies”, the results of the “prior” period have first been recalculated using the average exchange rates of the comparable period in the current year, and then compared with the results of the comparable period in the current year. <\/p>\n While constant currency calculations are not considered to be an IFRS measure, the Group believes these measures are critical to understanding its global revenue results and to compare with many of its competitors who report their financial results in U.S. dollars. Therefore, Dassault Syst\u00e8mes includes this calculation to compare IFRS and non-IFRS revenue figures for comparable periods. All information at constant currencies is expressed as a rounded percentage and therefore may not precisely reflect the absolute figures. <\/p>\n Information on Growth excluding acquisitions (“organic growth”) <\/p>\n In addition to financial indicators relating to the Group’s entire scope, Dassault Syst\u00e8mes also provides growth information excluding acquisitions’ effects, and named organic growth. To do so, the Group’s data is restated to exclude acquisitions, from the date of the transaction, over a period of 12 months. <\/p>\n Information on Industrial Sectors <\/p>\n Dassault Syst\u00e8mes provides end-to-end software solutions and services: its AI native 3D UNIV+RSES – made of multiple virtual twin experiences that are powered by the 3DEXPERIENCE platform – combine artificial intelligence (AI), modeling, simulation, data science, and collaborative innovation to support companies in the three sectors it serves, namely Manufacturing Industries, Life Sciences & Healthcare, and Infrastructure & Cities. <\/p>\n These three sectors comprise twelve industries: <\/p>\n Manufacturing Industries: Transportation & Mobility; Aerospace & Defense; Marine & Offshore; Industrial Equipment; High-Tech; Home & Lifestyle; Consumer Packaged Goods \u2013 Retail. In Manufacturing Industries, Dassault Syst\u00e8mes helps customers virtualize their operations, improve data sharing and collaboration across their organization, reduce costs and time-to-market, and become more sustainable; <\/p>\n Life Sciences & Healthcare: Life Sciences & Healthcare. In this sector, the Group aims to address the entire cycle of the patient’s journey and lead the way toward precision medicine. To reach the broader healthcare ecosystem from research to commercialization, the Group’s solutions connect all elements from molecule development to prevention and care, and combine new therapeutics, medical practices, as well as Medtech; <\/p>\n Infrastructure & Cities: Infrastructure, Energy & Materials; Architecture, Engineering & Construction; Business Services; Cities & Public Services. In this sector, the Group supports the virtualization of infrastructure and cities, making its industries more efficient and sustainable, and creating desirable living environments. <\/p>\n Information on Product Lines <\/p>\n The Group’s financial reporting on product lines includes the following information: <\/p>\n Industrial Innovation software revenue, which includes mainly CATIA, ENOVIA, SIMULIA, DELMIA and GEOVIA brands; <\/p>\n Life Sciences software revenue, which includes MEDIDATA and BIOVIA brands; <\/p>\n Mainstream Innovation software revenue which includes its CENTRIC and 3DVIA brands, as well as the SOLIDWORKS brand and its expanded offerings in design, simulation, PLM, and manufacturing. <\/p>\n OUTSCALE has been a Dassault Syst\u00e8mes brand since 2022, extending the portfolio of software applications. As the first sovereign and sustainable operator on the cloud, OUTSCALE enables governments and corporations from all sectors to achieve digital autonomy through a Cloud experience and with a world-class cyber governance. <\/p>\n GEOs <\/p>\n Eleven GEOs are responsible for driving the development of the Company’s business and implementing its customer-centric engagement model. Teams leverage strong networks of local customers, users, partners, and influencers. <\/p>\n These GEOs are structured into three groups: <\/p>\n the “Americas” group, made of two GEOs; <\/p>\n the “Europe” group, comprising Europe, Middle East and Africa (EMEA) and made of four GEOs; <\/p>\n the “Asia” group, comprising Asia and Oceania and made of five GEOs. <\/p>\n 3DEXPERIENCE Software Contribution <\/p>\n To measure the relative share of 3DEXPERIENCE software in its revenue, Dassault Syst\u00e8mes calculates the percentage contribution by comparing total 3DEXPERIENCE software revenue to software revenue for all product lines except SOLIDWORKS, MEDIDATA, CENTRIC and other acquisitions (defined as “3DEXPERIENCE eligible software revenue”). <\/p>\n Software revenue <\/p>\n Software license revenue represents fees earned from granting customers licenses to use Dassault Syst\u00e8mes’ software. It includes license revenue of perpetual and periodic license sales of software products. <\/p>\n Subscription contracts generally have a term of between one and five years, and include on premise software license and support. Support revenue represents periodic fees associated with the sale of unspecified product updates on a when-and-if-\u200aavailable basis and technical support. Support agreements are entered into in connection with the initial software license purchase. Support may be renewed by the customer at the conclusion of each term. <\/p>\n Recurring fees for subscription and support are reported within “Software Revenue”. <\/p>\n Annual Run Rate (ARR) <\/p>\n ARR is the annual value of all active subscription software, SaaS, hosting & support contracts as of the end of the reporting period. <\/p>\n The value of active contracts is annualized by dividing the total active contract value by the contract duration in days (end date minus start date), then multiplying the result by 360 days. <\/p>\n The value of an active contract refers to contract value for which orders have been submitted. <\/p>\n For contracts that include annual values that change over time, we include in ARR only the annual value of components of the contract that are considered active as of the date of the ARR calculation. <\/p>\n A contract or a component of the contract is considered active only between the contractual start and end dates. <\/p>\n For ramp contracts, only the portion where the customer has already submitted an order is included. Future ramped amounts are excluded until they are activated. <\/p>\n For MEDIDATA “Study by Study” contracts that are not contractually renewable, only the contractually committed portion is counted in the Group ARR. <\/p>\n No assumptions are taken regarding future customer renewals or future committed increases. <\/p>\n ARR is composed of 2 elements: subscription annual run rate (SARR) and maintenance annual run rate (MARR). <\/p>\n We believe ARR is a valuable operating measure to assess the health of our recurring business because it is aligned with the amount that we invoice the customer on an annual basis. We generally invoice customers annually for the current year of the active contract. <\/p>\n ARR increases by the annual value of active contracts that commence in a reporting period and decreases by the annual value of contracts that expire in the reporting period. <\/p>\n ARR is not annual recurring revenue, and is therefore not affected by revenue recognition standards, including point in time revenue recognition of on-premise license subscriptions. <\/p>\n DASSAULT SYST\u00c8MES <\/p>\n NON-IFRS FINANCIAL INFORMATION <\/p>\n (unaudited; in millions of Euros, except per share data, percentages, headcount and exchange rates) <\/p>\n Non-IFRS key figures exclude the effects of adjusting the carrying value of acquired companies’ contract liabilities (deferred revenue), share-based compensation expense, including related social charges, amortization of acquired intangible assets and of tangible assets revaluation, lease incentives of acquired companies, other operating income and expense, net, including the acquisition, integration, information systems transformation projects and restructuring expenses, and impairment of goodwill and acquired intangible assets, certain one-time items included in financial loss, net, certain one-time tax effects and the income tax effects of these non-IFRS adjustments. <\/p>\n Comparable IFRS financial information and a reconciliation of the IFRS and non-IFRS measures are set forth in the separate tables within this Attachment. <\/p>\n In millions of Euros, except per share data, percentages, headcount and exchange rates<\/p>\n Non-IFRS reported <\/p>\n Three months ended <\/p>\n Six months ended <\/p>\n June 30,<\/p>\n 2026 <\/p>\n June 30,<\/p>\n 2025 <\/p>\n Change <\/p>\n Change in constant currencies <\/p>\n June 30,<\/p>\n 2026 <\/p>\n June 30,<\/p>\n 2025 <\/p>\n Change <\/p>\n Change in constant currencies <\/p>\n Total Revenue <\/p>\n \u20ac 1,555.8 <\/p>\n \u20ac 1,523.2 <\/p>\n 2% <\/p>\n 4% <\/p>\n \u20ac 3,065.5 <\/p>\n \u20ac 3,096.2 <\/p>\n (1)% <\/p>\n 3% <\/p>\n Revenue breakdown by activity <\/p>\n Software revenue <\/p>\n 1,400.7 <\/p>\n 1,374.2 <\/p>\n 2% <\/p>\n 4% <\/p>\n 2,776.0 <\/p>\n 2,807.0 <\/p>\n (1)% <\/p>\n 3% <\/p>\n Of which licenses and other software revenue <\/p>\n 271.7 <\/p>\n 275.6 <\/p>\n (1)% <\/p>\n 1% <\/p>\n 471.8 <\/p>\n 473.7 <\/p>\n (0)% <\/p>\n 4% <\/p>\n Of which subscription and support revenue <\/p>\n 1,128.9 <\/p>\n 1,098.6 <\/p>\n 3% <\/p>\n 5% <\/p>\n 2,304.2 <\/p>\n 2,333.2 <\/p>\n (1)% <\/p>\n 3% <\/p>\n Services revenue <\/p>\n 155.2 <\/p>\n 148.9 <\/p>\n 4% <\/p>\n 6% <\/p>\n 289.5 <\/p>\n 289.2 <\/p>\n 0% <\/p>\n 5% <\/p>\n Software revenue breakdown by product line <\/p>\n Industrial Innovation <\/p>\n 768.0 <\/p>\n 744.6 <\/p>\n 3% <\/p>\n 5% <\/p>\n 1,517.6 <\/p>\n 1,537.7 <\/p>\n (1)% <\/p>\n 2% <\/p>\n Life Sciences <\/p>\n 252.2 <\/p>\n 268.3 <\/p>\n (6)% <\/p>\n (4)% <\/p>\n 511.0 <\/p>\n 560.9 <\/p>\n (9)% <\/p>\n (3)% <\/p>\n Mainstream Innovation <\/p>\n 380.5 <\/p>\n 361.3 <\/p>\n 5% <\/p>\n 8% <\/p>\n 747.4 <\/p>\n 708.3 <\/p>\n 6% <\/p>\n 11% <\/p>\n Software Revenue breakdown by geography <\/p>\n Americas <\/p>\n 524.0 <\/p>\n 505.0 <\/p>\n 4% <\/p>\n 5% <\/p>\n 1,070.8 <\/p>\n 1,116.2 <\/p>\n (4)% <\/p>\n 2% <\/p>\n Europe <\/p>\n 529.9 <\/p>\n 534.8 <\/p>\n (1)% <\/p>\n (0)% <\/p>\n 1,068.1 <\/p>\n 1,048.0 <\/p>\n 2% <\/p>\n 3% <\/p>\n Asia <\/p>\n 346.8 <\/p>\n 334.4 <\/p>\n 4% <\/p>\n 8% <\/p>\n 637.1 <\/p>\n 642.8 <\/p>\n (1)% <\/p>\n 6% <\/p>\n Operating income <\/p>\n \u20ac 466.7 <\/p>\n \u20ac 446.1 <\/p>\n 5% <\/p>\n \u20ac 923.6 <\/p>\n \u20ac 932.2 <\/p>\n (1)% <\/p>\n Operating margin <\/p>\n 30.0% <\/p>\n 29.3% <\/p>\n 30.1% <\/p>\n 30.1% <\/p>\n Net income attributable to shareholders <\/p>\n \u20ac 409.5 <\/p>\n \u20ac 391.0 <\/p>\n 5% <\/p>\n \u20ac 806.3 <\/p>\n \u20ac 811.2 <\/p>\n (1)% <\/p>\n Diluted earnings per share <\/p>\n \u20ac 0.31 <\/p>\n \u20ac 0.30 <\/p>\n 5% <\/p>\n 8% <\/p>\n \u20ac 0.61 <\/p>\n \u20ac 0.61 <\/p>\n (1)% <\/p>\n 6% <\/p>\n Closing headcount <\/p>\n 25,512 <\/p>\n 26,253 <\/p>\n (3)% <\/p>\n 25,512 <\/p>\n 26,253 <\/p>\n (3)% <\/p>\n Average Rate USD per Euro <\/p>\n 1.16 <\/p>\n 1.13 <\/p>\n 3% <\/p>\n 1.17 <\/p>\n 1.09 <\/p>\n 7% <\/p>\n Average Rate JPY per Euro <\/p>\n 185.34 <\/p>\n 163.81 <\/p>\n 13% <\/p>\n 184.46 <\/p>\n 162.12 <\/p>\n 14% <\/p>\n DASSAULT SYST\u00c8MES <\/p>\n ACQUISITIONS AND FOREIGN EXCHANGE IMPACT <\/p>\n (unaudited; in millions of Euros) <\/p>\n In millions of Euros<\/p>\n Non-IFRS reported <\/p>\n o\/w growth at constant rate and scope<\/p>\n o\/w change of scope impact at current year rate<\/p>\n o\/w FX impact on previous year figures<\/p>\n June 30,<\/p>\n 2026 <\/p>\n June 30,<\/p>\n 2025 <\/p>\n Change <\/p>\n Revenue QTD <\/p>\n 1,555.8 <\/p>\n 1,523.2 <\/p>\n 32.7 <\/p>\n 60.8 <\/p>\n 0.6 <\/p>\n (28.7) <\/p>\n Revenue YTD <\/p>\n 3,065.5 <\/p>\n 3,096.2 <\/p>\n (30.7) <\/p>\n 102.4 <\/p>\n 0.6 <\/p>\n (133.7) <\/p>\n DASSAULT SYST\u00c8MES <\/p>\n CONDENSED CONSOLIDATED STATEMENTS OF INCOME <\/p>\n (unaudited; in millions of Euros, except per share data and percentages) <\/p>\n In millions of Euros, except per share data and percentages<\/p>\n IFRS reported <\/p>\n Three months ended <\/p>\n Six months ended <\/p>\n June 30, <\/p>\n June 30, <\/p>\n June 30, <\/p>\n June 30, <\/p>\n 2026 <\/p>\n 2025 <\/p>\n 2026 <\/p>\n 2025 <\/p>\n Licenses and other software revenue <\/p>\n 271.7 <\/p>\n 275.6 <\/p>\n 471.8 <\/p>\n 473.7 <\/p>\n Subscription and Support revenue <\/p>\n 1,128.9 <\/p>\n 1,097.1 <\/p>\n 2,303.7 <\/p>\n 2,331.7 <\/p>\n Software revenue <\/p>\n 1,400.6 <\/p>\n 1,372.7 <\/p>\n 2,775.5 <\/p>\n 2,805.4 <\/p>\n Services revenue <\/p>\n 155.2 <\/p>\n 148.9 <\/p>\n 289.5 <\/p>\n 289.2 <\/p>\n Total Revenue <\/p>\n \u20ac 1,555.8 <\/p>\n \u20ac 1,521.6 <\/p>\n \u20ac 3,065.0 <\/p>\n \u20ac 3,094.6 <\/p>\n Cost of software revenue (1) <\/p>\n (106.7) <\/p>\n (120.1) <\/p>\n (221.3) <\/p>\n (249.3) <\/p>\n Cost of services revenue <\/p>\n (140.9) <\/p>\n (144.6) <\/p>\n (267.4) <\/p>\n (275.7) <\/p>\n Research and development expenses <\/p>\n (333.1) <\/p>\n (348.7) <\/p>\n (651.8) <\/p>\n (697.3) <\/p>\n Marketing and sales expenses <\/p>\n (420.9) <\/p>\n (448.0) <\/p>\n (838.0) <\/p>\n (894.5) <\/p>\n General and administrative expenses <\/p>\n (103.8) <\/p>\n (123.7) <\/p>\n (203.2) <\/p>\n (244.2) <\/p>\n Amortization of acquired intangible assets and of tangible assets revaluation <\/p>\n (80.6) <\/p>\n (85.4) <\/p>\n (160.6) <\/p>\n (173.8) <\/p>\n Other operating income and expense, net <\/p>\n (11.5) <\/p>\n (9.3) <\/p>\n (16.7) <\/p>\n (13.7) <\/p>\n Total Operating Expenses <\/p>\n (1,197.5) <\/p>\n (1,279.9) <\/p>\n (2,359.1) <\/p>\n (2,548.4) <\/p>\n Operating Income <\/p>\n \u20ac 358.3 <\/p>\n \u20ac 241.7 <\/p>\n \u20ac 705.9 <\/p>\n \u20ac 546.1 <\/p>\n Financial income (loss), net <\/p>\n 24.1 <\/p>\n 29.9 <\/p>\n 46.3 <\/p>\n 60.2 <\/p>\n Income before income taxes <\/p>\n \u20ac 382.4 <\/p>\n \u20ac 271.5 <\/p>\n \u20ac 752.2 <\/p>\n \u20ac 606.3 <\/p>\n Income tax expense <\/p>\n (63.1) <\/p>\n (53.0) <\/p>\n (140.4) <\/p>\n (128.4) <\/p>\n Net Income <\/p>\n \u20ac 319.3 <\/p>\n \u20ac 218.6 <\/p>\n \u20ac 611.8 <\/p>\n \u20ac 477.9 <\/p>\n Non-controlling interest <\/p>\n 0.0 <\/p>\n 4.9 <\/p>\n 0.0 <\/p>\n 6.1 <\/p>\n Net Income attributable to equity holders of the parent <\/p>\n \u20ac 319.3 <\/p>\n \u20ac 223.5 <\/p>\n \u20ac 611.8 <\/p>\n \u20ac 484.0 <\/p>\n Basic earnings per share <\/p>\n 0.24 <\/p>\n 0.17 <\/p>\n 0.46 <\/p>\n 0.37 <\/p>\n Diluted earnings per share <\/p>\n \u20ac 0.22 <\/p>\n \u20ac 0.17 <\/p>\n \u20ac 0.44 <\/p>\n \u20ac 0.37 <\/p>\n Basic weighted average shares outstanding (in millions) <\/p>\n 1,320.6 <\/p>\n 1,315.9 <\/p>\n 1,320.6 <\/p>\n 1,314.9 <\/p>\n Diluted weighted average shares outstanding (in millions) <\/p>\n 1,325.3 <\/p>\n 1,324.4 <\/p>\n 1,326.1 <\/p>\n 1,325.7 <\/p>\n (1) Excluding amortization of acquired intangible assets and of tangible assets revaluation. <\/p>\n IFRS reported<\/p>\n Three months ended June 30, 2026 <\/p>\n Six months ended June 30, 2026 <\/p>\n Change (2) <\/p>\n Change in constant currencies <\/p>\n Change (2) <\/p>\n Change in constant currencies <\/p>\n Total Revenue <\/p>\n 2% <\/p>\n 4% <\/p>\n (1)% <\/p>\n 4% <\/p>\n Revenue by activity <\/p>\n Software revenue <\/p>\n 2% <\/p>\n 4% <\/p>\n (1)% <\/p>\n 3% <\/p>\n Services revenue <\/p>\n 4% <\/p>\n 6% <\/p>\n 0% <\/p>\n 5% <\/p>\n Software Revenue by product line <\/p>\n Industrial Innovation <\/p>\n 3% <\/p>\n 5% <\/p>\n (1)% <\/p>\n 2% <\/p>\n Life Sciences <\/p>\n (6)% <\/p>\n (4)% <\/p>\n (9)% <\/p>\n (3)% <\/p>\n Mainstream Innovation <\/p>\n 6% <\/p>\n 8% <\/p>\n 6% <\/p>\n 11% <\/p>\n Software Revenue by geography <\/p>\n Americas <\/p>\n 4% <\/p>\n 6% <\/p>\n (4)% <\/p>\n 2% <\/p>\n Europe <\/p>\n (1)% <\/p>\n (0)% <\/p>\n 2% <\/p>\n 3% <\/p>\n Asia <\/p>\n 4% <\/p>\n 8% <\/p>\n (1)% <\/p>\n 6% <\/p>\n (2) Variation compared to the same period in the prior year. <\/p>\n DASSAULT SYST\u00c8MES <\/p>\n CONDENSED CONSOLIDATED BALANCE SHEET <\/p>\n (unaudited; in millions of Euros) <\/p>\n In millions of Euros<\/p>\n IFRS reported <\/p>\n June 30, <\/p>\n December 31, <\/p>\n 2026 <\/p>\n 2025 <\/p>\n ASSETS <\/p>\n Cash and cash equivalents <\/p>\n 5,660.1 <\/p>\n 4,125.4 <\/p>\n Trade accounts receivable, net <\/p>\n 1,801.5 <\/p>\n 2,168.4 <\/p>\n Contract assets <\/p>\n 53.3 <\/p>\n 37.3 <\/p>\n Other current assets <\/p>\n 392.6 <\/p>\n 454.4 <\/p>\n Total current assets <\/p>\n 7,907.4 <\/p>\n 6,785.5 <\/p>\n Property and equipment, net <\/p>\n 952.1 <\/p>\n 944.8 <\/p>\n Goodwill and Intangible assets, net <\/p>\n 6,887.0 <\/p>\n 6,868.8 <\/p>\n Other non-current assets <\/p>\n 571.1 <\/p>\n 460.4 <\/p>\n Total non-current assets <\/p>\n 8,410.3 <\/p>\n 8,274.0 <\/p>\n Total Assets <\/p>\n \u20ac 16,317.7 <\/p>\n \u20ac 15,059.4 <\/p>\n LIABILITIES <\/p>\n Trade accounts payable <\/p>\n 241.8 <\/p>\n 253.0 <\/p>\n Contract liabilities <\/p>\n 1,642.7 <\/p>\n 1,536.0 <\/p>\n Borrowings, current <\/p>\n 1,237.5 <\/p>\n 1,449.5 <\/p>\n Other current liabilities <\/p>\n 854.4 <\/p>\n 990.9 <\/p>\n Total current liabilities <\/p>\n 3,976.4 <\/p>\n 4,229.3 <\/p>\n Borrowings, non-current <\/p>\n 2,140.2 <\/p>\n 1,145.8 <\/p>\n Other non-current liabilities <\/p>\n 878.0 <\/p>\n 886.4 <\/p>\n Total non-current liabilities <\/p>\n 3,018.1 <\/p>\n 2,032.2 <\/p>\n Non-controlling interests <\/p>\n 5.4 <\/p>\n 5.4 <\/p>\n Parent shareholders’ equity <\/p>\n 9,317.8 <\/p>\n 8,792.5 <\/p>\n Total Liabilities <\/p>\n \u20ac 16,317.7 <\/p>\n \u20ac 15,059.4 <\/p>\n DASSAULT SYST\u00c8MES <\/p>\n CONDENSED CONSOLIDATED CASH FLOW STATEMENT <\/p>\n (unaudited; in millions of Euros) <\/p>\n In millions of Euros<\/p>\n IFRS reported <\/p>\n Three months ended <\/p>\n Six months ended <\/p>\n June 30, <\/p>\n June 30, <\/p>\n Change<\/p>\n June 30, <\/p>\n June 30, <\/p>\n Change<\/p>\n 2026 <\/p>\n 2025 <\/p>\n 2026 <\/p>\n 2025 <\/p>\n Net income attributable to equity holders of the parent <\/p>\n 319.3 <\/p>\n 223.5 <\/p>\n 95.8 <\/p>\n 611.8 <\/p>\n 484.0 <\/p>\n 127.8 <\/p>\n Non-controlling interest <\/p>\n (0.0) <\/p>\n (4.9) <\/p>\n 4.9 <\/p>\n (0.0) <\/p>\n (6.1) <\/p>\n 6.1 <\/p>\n Net income <\/p>\n 319.3 <\/p>\n 218.6 <\/p>\n 100.7 <\/p>\n 611.8 <\/p>\n 477.9 <\/p>\n 133.9 <\/p>\n Depreciation of property and equipment <\/p>\n 52.4 <\/p>\n 48.5 <\/p>\n 3.9 <\/p>\n 104.7 <\/p>\n 98.9 <\/p>\n 5.8 <\/p>\n Amortization of intangible assets <\/p>\n 81.6 <\/p>\n 86.2 <\/p>\n (4.6) <\/p>\n 162.7 <\/p>\n 175.9 <\/p>\n (13.2) <\/p>\n Adjustments for other non-cash items <\/p>\n 3.3 <\/p>\n 20.5 <\/p>\n (17.1) <\/p>\n (4.6) <\/p>\n 36.6 <\/p>\n (41.3) <\/p>\n Changes in working capital <\/p>\n (168.3) <\/p>\n (39.4) <\/p>\n (128.9) <\/p>\n 362.6 <\/p>\n 358.0 <\/p>\n 4.6 <\/p>\n Net Cash From Operating Activities <\/p>\n \u20ac 288.3 <\/p>\n \u20ac 334.3 <\/p>\n \u20ac (46.0) <\/p>\n \u20ac 1,237.1 <\/p>\n \u20ac 1,147.3 <\/p>\n \u20ac 89.8 <\/p>\n Additions to property, equipment and intangibles assets <\/p>\n (40.6) <\/p>\n (39.3) <\/p>\n (1.3) <\/p>\n (64.3) <\/p>\n (95.3) <\/p>\n 31.0 <\/p>\n Payment for acquisition of businesses, net of cash acquired <\/p>\n (2.6) <\/p>\n (9.2) <\/p>\n 6.6 <\/p>\n (13.9) <\/p>\n (202.9) <\/p>\n 189.0 <\/p>\n Other <\/p>\n (2.9) <\/p>\n 3.2 <\/p>\n (6.1) <\/p>\n (12.9) <\/p>\n (34.6) <\/p>\n 21.7 <\/p>\n Net Cash Provided by (Used in) Investing Activities <\/p>\n \u20ac (46.1) <\/p>\n \u20ac (45.3) <\/p>\n \u20ac (0.8) <\/p>\n \u20ac (91.1) <\/p>\n \u20ac (332.8) <\/p>\n \u20ac 241.7 <\/p>\n Proceeds from exercise of stock options <\/p>\n 14.1 <\/p>\n 7.4 <\/p>\n 6.6 <\/p>\n 15.1 <\/p>\n 29.6 <\/p>\n (14.5) <\/p>\n Cash dividends paid <\/p>\n (357.5) <\/p>\n (342.6) <\/p>\n (14.9) <\/p>\n (357.5) <\/p>\n (342.6) <\/p>\n (14.9) <\/p>\n Repurchase and sale of treasury stock <\/p>\n 4.4 <\/p>\n (144.7) <\/p>\n 149.2 <\/p>\n (59.9) <\/p>\n (224.8) <\/p>\n 164.9 <\/p>\n Capital increase <\/p>\n (0.0) <\/p>\n 111.3 <\/p>\n (111.3) <\/p>\n – <\/p>\n 111.3 <\/p>\n (111.3) <\/p>\n Acquisition of non-controlling interests <\/p>\n – <\/p>\n 0.0 <\/p>\n (0.0) <\/p>\n – <\/p>\n (0.2) <\/p>\n 0.2 <\/p>\n Proceeds from borrowings <\/p>\n 997.3 <\/p>\n 121.3 <\/p>\n 876.0 <\/p>\n 997.3 <\/p>\n 81.0 <\/p>\n 916.3 <\/p>\n Repayment of borrowings <\/p>\n (99.2) <\/p>\n – <\/p>\n (99.2) <\/p>\n (217.0) <\/p>\n (18.5) <\/p>\n (198.5) <\/p>\n Repayment of lease liabilities <\/p>\n (33.7) <\/p>\n (22.7) <\/p>\n (10.9) <\/p>\n (60.2) <\/p>\n (45.4) <\/p>\n (14.8) <\/p>\n Net Cash Provided by (Used in) Financing Activities <\/p>\n \u20ac 525.4 <\/p>\n \u20ac (270.0) <\/p>\n \u20ac 795.4 <\/p>\n \u20ac 317.9 <\/p>\n \u20ac (409.5) <\/p>\n \u20ac 727.5 <\/p>\n Effect of exchange rate changes on cash and cash equivalents <\/p>\n 17.5 <\/p>\n (178.1) <\/p>\n 195.7 <\/p>\n 70.7 <\/p>\n (273.9) <\/p>\n 344.5 <\/p>\n Increase (decrease) in cash and cash equivalents <\/p>\n \u20ac 785.1 <\/p>\n \u20ac (159.1) <\/p>\n \u20ac 944.2 <\/p>\n \u20ac 1,534.6 <\/p>\n \u20ac 131.2 <\/p>\n \u20ac 1,403.5 <\/p>\n Cash and cash equivalents at beginning of period <\/p>\n \u20ac 4,874.9 <\/p>\n \u20ac 4,242.9 <\/p>\n \u20ac 4,125.4 <\/p>\n \u20ac 3,952.6 <\/p>\n Cash and cash equivalents at end of period <\/p>\n \u20ac 5,660.1 <\/p>\n \u20ac 4,083.7 <\/p>\n \u20ac 5,660.1 <\/p>\n \u20ac 4,083.7 <\/p>\n DASSAULT SYST\u00c8MES Readers are cautioned that the supplemental non-IFRS information presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Group’s supplemental non-IFRS financial information may not be comparable to similarly titled “non-IFRS” measures used by other companies. Further specific limitations for individual non-IFRS measures, and the reasons for presenting non-IFRS financial information, are set forth in the Group’s Document d’Enregistrement Universel for the year ended December 31, 2025 filed with the AMF on March 31, 2026. To compensate for these limitations, the supplemental non-IFRS financial information should be read not in isolation, but only in conjunction with the Group’s consolidated financial statements prepared in accordance with IFRS. <\/p>\n In millions of Euros, except per share data and percentages<\/p>\n Three months ended June 30, <\/p>\n Change <\/p>\n 2026 <\/p>\n Adjustment(1)<\/p>\n 2026 <\/p>\n 2025 <\/p>\n Adjustment(1)<\/p>\n 2025 <\/p>\n IFRS<\/p>\n Non-IFRS(2)<\/p>\n IFRS <\/p>\n Non-IFRS <\/p>\n IFRS <\/p>\n Non-IFRS <\/p>\n Total Revenue <\/p>\n \u20ac 1,555.8 <\/p>\n \u20ac 0.1 <\/p>\n \u20ac 1,555.8 <\/p>\n \u20ac 1,521.6 <\/p>\n \u20ac 1.6 <\/p>\n \u20ac 1,523.2 <\/p>\n 2% <\/p>\n 2% <\/p>\n Revenue breakdown by activity <\/p>\n Software revenue <\/p>\n 1,400.6 <\/p>\n 0.1 <\/p>\n 1,400.7 <\/p>\n 1,372.7 <\/p>\n 1.6 <\/p>\n 1,374.2 <\/p>\n 2% <\/p>\n 2% <\/p>\n Licenses and other software revenue <\/p>\n 271.7 <\/p>\n – <\/p>\n 271.7 <\/p>\n 275.6 <\/p>\n – <\/p>\n 275.6 <\/p>\n (1)% <\/p>\n (1)% <\/p>\n Subscription and Support revenue <\/p>\n 1,128.9 <\/p>\n 0.1 <\/p>\n 1,128.9 <\/p>\n 1,097.1 <\/p>\n 1.6 <\/p>\n 1,098.6 <\/p>\n 3% <\/p>\n 3% <\/p>\n Recurring portion of Software revenue <\/p>\n 81% <\/p>\n 81% <\/p>\n 80% <\/p>\n 80% <\/p>\n Services revenue <\/p>\n 155.2 <\/p>\n – <\/p>\n 155.2 <\/p>\n 148.9 <\/p>\n – <\/p>\n 148.9 <\/p>\n 4% <\/p>\n 4% <\/p>\n Software Revenue breakdown by product line <\/p>\n Industrial Innovation <\/p>\n 768.0 <\/p>\n – <\/p>\n 768.0 <\/p>\n 744.6 <\/p>\n – <\/p>\n 744.6 <\/p>\n 3% <\/p>\n 3% <\/p>\n Life Sciences <\/p>\n 252.2 <\/p>\n – <\/p>\n 252.2 <\/p>\n 268.3 <\/p>\n – <\/p>\n 268.3 <\/p>\n (6)% <\/p>\n (6)% <\/p>\n Mainstream Innovation <\/p>\n 380.4 <\/p>\n 0.1 <\/p>\n 380.5 <\/p>\n 359.7 <\/p>\n 1.6 <\/p>\n 361.3 <\/p>\n 6% <\/p>\n 5% <\/p>\n Software Revenue breakdown by geography <\/p>\n Americas <\/p>\n 524.0 <\/p>\n – <\/p>\n 524.0 <\/p>\n 505.0 <\/p>\n – <\/p>\n 505.0 <\/p>\n 4% <\/p>\n 4% <\/p>\n Europe <\/p>\n 529.9 <\/p>\n – <\/p>\n 529.9 <\/p>\n 533.4 <\/p>\n 1.4 <\/p>\n 534.8 <\/p>\n (1)% <\/p>\n (1)% <\/p>\n Asia <\/p>\n 346.8 <\/p>\n – <\/p>\n 346.8 <\/p>\n 334.3 <\/p>\n 0.1 <\/p>\n 334.4 <\/p>\n 4% <\/p>\n 4% <\/p>\n Total Operating Expenses <\/p>\n \u20ac (1,197.5) <\/p>\n \u20ac 108.3 <\/p>\n \u20ac (1,089.2) <\/p>\n \u20ac (1,279.9) <\/p>\n \u20ac 202.9 <\/p>\n \u20ac (1,077.1) <\/p>\n (6)% <\/p>\n 1% <\/p>\n Share-based compensation expense and related social charges <\/p>\n (15.8) <\/p>\n 15.8 <\/p>\n – <\/p>\n (107.7) <\/p>\n 107.7 <\/p>\n – <\/p>\n Amortization of acquired intangible assets and of tangible assets revaluation <\/p>\n (80.6) <\/p>\n 80.6 <\/p>\n – <\/p>\n (85.4) <\/p>\n 85.4 <\/p>\n – <\/p>\n Lease incentives of acquired companies <\/p>\n (0.4) <\/p>\n 0.4 <\/p>\n – <\/p>\n (0.4) <\/p>\n 0.4 <\/p>\n – <\/p>\n Other operating income and expense, net <\/p>\n (11.5) <\/p>\n 11.5 <\/p>\n – <\/p>\n (9.3) <\/p>\n 9.3 <\/p>\n – <\/p>\n Operating Income <\/p>\n \u20ac 358.3 <\/p>\n \u20ac 108.3 <\/p>\n \u20ac 466.7 <\/p>\n \u20ac 241.7 <\/p>\n \u20ac 204.4 <\/p>\n \u20ac 446.1 <\/p>\n 48% <\/p>\n 5% <\/p>\n Operating Margin <\/p>\n 23.0% <\/p>\n 30.0% <\/p>\n 15.9% <\/p>\n 29.3% <\/p>\n Financial income (loss), net <\/p>\n 24.1 <\/p>\n 1.1 <\/p>\n 25.2 <\/p>\n 29.9 <\/p>\n 0.6 <\/p>\n 30.4 <\/p>\n (19)% <\/p>\n (17)% <\/p>\n Income tax expense <\/p>\n (63.1) <\/p>\n (19.3) <\/p>\n (82.4) <\/p>\n (53.0) <\/p>\n (32.8) <\/p>\n (85.7) <\/p>\n 19% <\/p>\n (4)% <\/p>\n Non-controlling interest <\/p>\n 0.0 <\/p>\n 0.0 <\/p>\n 0.0 <\/p>\n 4.9 <\/p>\n (4.7) <\/p>\n 0.3 <\/p>\n (100)% <\/p>\n (88)% <\/p>\n Net Income attributable to shareholders <\/p>\n \u20ac 319.3 <\/p>\n \u20ac 90.2 <\/p>\n \u20ac 409.5 <\/p>\n \u20ac 223.5 <\/p>\n \u20ac 167.6 <\/p>\n \u20ac 391.0 <\/p>\n 43% <\/p>\n 5% <\/p>\n Diluted Earnings Per Share (3) <\/p>\n \u20ac 0.22 <\/p>\n \u20ac 0.08 <\/p>\n \u20ac 0.31 <\/p>\n \u20ac 0.17 <\/p>\n \u20ac 0.13 <\/p>\n \u20ac 0.30 <\/p>\n 33% <\/p>\n 5% <\/p>\n (1) In the reconciliation schedule above, (i) all adjustments to IFRS revenue data reflect the exclusion of the deferred revenue adjustment of acquired companies; (ii) adjustments to IFRS operating expense data reflect the exclusion of the amortization of acquired intangibles assets and of tangible assets revaluation, share-based compensation expense, and related social charges, the effect of adjusting the lease incentives of acquired companies, as detailed below, and other operating income and expense, net including acquisition, integration, information systems transformation projects and restructuring expenses, and impairment of goodwill and acquired intangible assets; (iii) adjustments to IFRS financial income, net reflect the exclusion of certain one-time items, net, and; (iv) all adjustments to IFRS net income data reflect the combined effect of these adjustments, and with respect to net income and diluted net income per share, certain one-time tax effects and the income tax effect of the non-IFRS adjustments. <\/p>\n In millions of Euros, except percentages<\/p>\n Three months ended June 30, <\/p>\n Change <\/p>\n 2026<\/p>\n IFRS <\/p>\n Share-based compensation expense and related social charges <\/p>\n Lease incentives of acquired companies <\/p>\n 2026<\/p>\n Non-IFRS <\/p>\n 2025<\/p>\n IFRS <\/p>\n Share-based compensation expense and related social charges <\/p>\n Lease incentives of acquired companies <\/p>\n 2025<\/p>\n Non-IFRS <\/p>\n IFRS <\/p>\n Non-<\/p>\n IFRS <\/p>\n Cost of revenue <\/p>\n (247.6) <\/p>\n (0.5) <\/p>\n 0.1 <\/p>\n (247.9) <\/p>\n (264.7) <\/p>\n 13.9 <\/p>\n 0.1 <\/p>\n (250.7) <\/p>\n (6)% <\/p>\n (1)% <\/p>\n Research and development expenses <\/p>\n (333.1) <\/p>\n 10.2 <\/p>\n 0.1 <\/p>\n (322.8) <\/p>\n (348.7) <\/p>\n 28.9 <\/p>\n 0.1 <\/p>\n (319.7) <\/p>\n (4)% <\/p>\n 1% <\/p>\n Marketing and sales expenses <\/p>\n (420.9) <\/p>\n 5.8 <\/p>\n 0.1 <\/p>\n (415.0) <\/p>\n (448.0) <\/p>\n 39.7 <\/p>\n 0.1 <\/p>\n (408.2) <\/p>\n (6)% <\/p>\n 2% <\/p>\n General and administrative expenses <\/p>\n (103.8) <\/p>\n 0.3 <\/p>\n 0.0 <\/p>\n (103.5) <\/p>\n (123.7) <\/p>\n 25.2 <\/p>\n 0.0 <\/p>\n (98.5) <\/p>\n (16)% <\/p>\n 5% <\/p>\n Total <\/p>\n \u20ac 15.8 <\/p>\n \u20ac 0.4 <\/p>\n \u20ac 107.7 <\/p>\n \u20ac 0.4 <\/p>\n (2) The non-IFRS percentage increase (decrease) compares non-IFRS measures for the two different periods. In the event there is non-IFRS adjustment to the relevant measure for only one of the periods under comparison, the non-IFRS increase (decrease) compares the non-IFRS measure to the relevant IFRS measure. DASSAULT SYST\u00c8MES Readers are cautioned that the supplemental non-IFRS information presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Group’s supplemental non-IFRS financial information may not be comparable to similarly titled “non-IFRS” measures used by other companies. Further specific limitations for individual non-IFRS measures, and the reasons for presenting non-IFRS financial information, are set forth in the Group’s Document d’Enregistrement Universel for the year ended December 31, 2025 filed with the AMF on March 31, 2026. To compensate for these limitations, the supplemental non-IFRS financial information should be read not in isolation, but only in conjunction with the Group’s consolidated financial statements prepared in accordance with IFRS. <\/p>\n In millions of Euros, except per share data and percentages<\/p>\n Six months ended June 30, <\/p>\n Change <\/p>\n 2026 <\/p>\n Adjustment(1)<\/p>\n 2026 <\/p>\n 2025 <\/p>\n Adjustment(1)<\/p>\n 2025 <\/p>\n IFRS<\/p>\n Non-IFRS(2)<\/p>\n IFRS <\/p>\n Non-IFRS <\/p>\n IFRS <\/p>\n Non-IFRS <\/p>\n Total Revenue <\/p>\n \u20ac 3,065.0 <\/p>\n \u20ac 0.5 <\/p>\n \u20ac 3,065.5 <\/p>\n \u20ac 3,094.6 <\/p>\n 1.6 <\/p>\n \u20ac 3,096.2 <\/p>\n (1)% <\/p>\n (1)% <\/p>\n Revenue breakdown by activity <\/p>\n Software revenue <\/p>\n 2,775.5 <\/p>\n 0.5 <\/p>\n 2,776.0 <\/p>\n 2,805.4 <\/p>\n 1.6 <\/p>\n 2,807.0 <\/p>\n (1)% <\/p>\n (1)% <\/p>\n Licenses and other software revenue <\/p>\n 471.8 <\/p>\n – <\/p>\n 471.8 <\/p>\n 473.7 <\/p>\n – <\/p>\n 473.7 <\/p>\n (0)% <\/p>\n (0)% <\/p>\n Subscription and Support revenue <\/p>\n 2,303.7 <\/p>\n 0.5 <\/p>\n 2,304.2 <\/p>\n 2,331.7 <\/p>\n 1.6 <\/p>\n 2,333.2 <\/p>\n (1)% <\/p>\n (1)% <\/p>\n Recurring portion of Software revenue <\/p>\n 83% <\/p>\n 83% <\/p>\n 83% <\/p>\n 83% <\/p>\n Services revenue <\/p>\n 289.5 <\/p>\n – <\/p>\n 289.5 <\/p>\n 289.2 <\/p>\n – <\/p>\n 289.2 <\/p>\n 0% <\/p>\n 0% <\/p>\n Software Revenue breakdown by product line <\/p>\n Industrial Innovation <\/p>\n 1,517.6 <\/p>\n – <\/p>\n 1,517.6 <\/p>\n 1,537.7 <\/p>\n – <\/p>\n 1,537.7 <\/p>\n (1)% <\/p>\n (1)% <\/p>\n Life Sciences <\/p>\n 511.0 <\/p>\n – <\/p>\n 511.0 <\/p>\n 560.9 <\/p>\n – <\/p>\n 560.9 <\/p>\n (9)% <\/p>\n (9)% <\/p>\n Mainstream Innovation <\/p>\n 747.0 <\/p>\n 0.5 <\/p>\n 747.4 <\/p>\n 706.8 <\/p>\n 1.6 <\/p>\n 708.3 <\/p>\n 6% <\/p>\n 6% <\/p>\n Software Revenue breakdown by geography <\/p>\n Americas <\/p>\n 1,070.8 <\/p>\n – <\/p>\n 1,070.8 <\/p>\n 1,116.1 <\/p>\n 0.1 <\/p>\n 1,116.2 <\/p>\n (4)% <\/p>\n (4)% <\/p>\n Europe <\/p>\n 1,067.7 <\/p>\n 0.4 <\/p>\n 1,068.1 <\/p>\n 1,046.6 <\/p>\n 1.4 <\/p>\n 1,048.0 <\/p>\n 2% <\/p>\n 2% <\/p>\n Asia <\/p>\n 637.1 <\/p>\n – <\/p>\n 637.1 <\/p>\n 642.7 <\/p>\n 0.1 <\/p>\n 642.8 <\/p>\n (1)% <\/p>\n (1)% <\/p>\n Total Operating Expenses <\/p>\n \u20ac (2,359.1) <\/p>\n \u20ac 217.3 <\/p>\n \u20ac (2,141.9) <\/p>\n \u20ac (2,548.4) <\/p>\n \u20ac 384.4 <\/p>\n \u20ac (2,164.0) <\/p>\n (7)% <\/p>\n (1)% <\/p>\n Share-based compensation expense and related social charges <\/p>\n (39.2) <\/p>\n 39.2 <\/p>\n – <\/p>\n (196.2) <\/p>\n 196.2 <\/p>\n – <\/p>\n Amortization of acquired intangible assets and of tangible assets revaluation <\/p>\n (160.6) <\/p>\n 160.6 <\/p>\n – <\/p>\n (173.8) <\/p>\n 173.8 <\/p>\n – <\/p>\n Lease incentives of acquired companies <\/p>\n (0.7) <\/p>\n 0.7 <\/p>\n – <\/p>\n (0.8) <\/p>\n 0.8 <\/p>\n – <\/p>\n Other operating income and expense, net <\/p>\n (16.7) <\/p>\n 16.7 <\/p>\n – <\/p>\n (13.7) <\/p>\n 13.7 <\/p>\n – <\/p>\n Operating Income <\/p>\n \u20ac 705.9 <\/p>\n \u20ac 217.8 <\/p>\n \u20ac 923.6 <\/p>\n \u20ac 546.1 <\/p>\n \u20ac 386.0 <\/p>\n \u20ac 932.2 <\/p>\n 29% <\/p>\n (1)% <\/p>\n Operating Margin <\/p>\n 23.0% <\/p>\n 30.1% <\/p>\n 17.6% <\/p>\n 30.1% <\/p>\n Financial income (loss), net <\/p>\n 46.3 <\/p>\n 1.8 <\/p>\n 48.1 <\/p>\n 60.2 <\/p>\n 1.1 <\/p>\n 61.3 <\/p>\n (23)% <\/p>\n (22)% <\/p>\n Income tax expense <\/p>\n (140.4) <\/p>\n (25.0) <\/p>\n (165.4) <\/p>\n (128.4) <\/p>\n (54.4) <\/p>\n (182.8) <\/p>\n 9% <\/p>\n (10)% <\/p>\n Non-controlling interest <\/p>\n 0.0 <\/p>\n (0.0) <\/p>\n 0.0 <\/p>\n 6.1 <\/p>\n (5.6) <\/p>\n 0.5 <\/p>\n (99)% <\/p>\n (99)% <\/p>\n Net Income attributable to shareholders <\/p>\n \u20ac 611.8 <\/p>\n \u20ac 194.5 <\/p>\n \u20ac 806.3 <\/p>\n \u20ac 484.0 <\/p>\n \u20ac 327.2 <\/p>\n \u20ac 811.2 <\/p>\n 26% <\/p>\n (1)% <\/p>\n Diluted Earnings Per Share (3) <\/p>\n \u20ac 0.44 <\/p>\n \u20ac 0.16 <\/p>\n \u20ac 0.61 <\/p>\n \u20ac 0.37 <\/p>\n \u20ac 0.25 <\/p>\n \u20ac 0.61 <\/p>\n 22% <\/p>\n (1)% <\/p>\n (1) In the reconciliation schedule above, (i) all adjustments to IFRS revenue data reflect the exclusion of the deferred revenue adjustment of acquired companies; (ii) adjustments to IFRS operating expense data reflect the exclusion of the amortization of acquired intangibles assets and of tangible assets revaluation, share-based compensation expense, and related social charges, the effect of adjusting the lease incentives of acquired companies, as detailed below, and other operating income and expense, net including acquisition, integration, information systems transformation projects and restructuring expenses, and impairment of goodwill and acquired intangible assets; (iii) adjustments to IFRS financial income, net reflect the exclusion of certain one-time items, net, and; (iv) all adjustments to IFRS net income data reflect the combined effect of these adjustments, and with respect to net income and diluted net income per share, certain one-time tax effects and the income tax effect of the non-IFRS adjustments. <\/p>\n In millions of Euros, except percentages<\/p>\n Six months ended June 30, <\/p>\n Change <\/p>\n 2026<\/p>\n IFRS <\/p>\n Share-based compensation expense and related social charges <\/p>\n Lease incentives of acquired companies <\/p>\n 2026<\/p>\n Non-IFRS <\/p>\n 2025<\/p>\n IFRS <\/p>\n Share-based compensation expense and related social charges <\/p>\n Lease incentives of acquired companies <\/p>\n 2025<\/p>\n Non-IFRS <\/p>\n IFRS <\/p>\n Non-<\/p>\n IFRS <\/p>\n Cost of revenue <\/p>\n (488.7) <\/p>\n 0.6 <\/p>\n 0.2 <\/p>\n (487.9) <\/p>\n (525.0) <\/p>\n 18.8 <\/p>\n 0.2 <\/p>\n (505.9) <\/p>\n (7)% <\/p>\n (4)% <\/p>\n Research and development expenses <\/p>\n (651.8) <\/p>\n 18.6 <\/p>\n 0.3 <\/p>\n (633.0) <\/p>\n (697.3) <\/p>\n 61.4 <\/p>\n 0.3 <\/p>\n (635.7) <\/p>\n (7)% <\/p>\n (0)% <\/p>\n Marketing and sales expenses <\/p>\n (838.0) <\/p>\n 11.5 <\/p>\n 0.2 <\/p>\n (826.4) <\/p>\n (894.5) <\/p>\n 64.2 <\/p>\n 0.2 <\/p>\n (830.1) <\/p>\n (6)% <\/p>\n (0)% <\/p>\n General and administrative expenses <\/p>\n (203.2) <\/p>\n 8.6 <\/p>\n 0.0 <\/p>\n (194.6) <\/p>\n (244.2) <\/p>\n 51.8 <\/p>\n 0.1 <\/p>\n (192.3) <\/p>\n (17)% <\/p>\n 1% <\/p>\n Total <\/p>\n \u20ac 39.2 <\/p>\n \u20ac 0.7 <\/p>\n \u20ac 196.2 <\/p>\n \u20ac 0.8 <\/p>\n (2) The non-IFRS percentage increase (decrease) compares non-IFRS measures for the two different periods. In the event there is non-IFRS adjustment to the relevant measure for only one of the periods under comparison, the non-IFRS increase (decrease) compares the non-IFRS measure to the relevant IFRS measure. 1 IFRS figures for 2Q26: Total revenue of \u20ac1.56 billion, operating margin of 23.0% compared to 15.9% in 2Q25, and diluted EPS of \u20ac0.22 compared to \u20ac0.17 in 2Q25. <\/p>\n 2 At FY26 plan currency rates <\/p>\n 3 At FY26 plan currency rates <\/p>\n 4 FY26 Plan foreign exchange rates used for all periods ($1.18 per euro and JPY 170.0 per euro) <\/p>\n Attachment <\/p>\n","protected":false},"excerpt":{"rendered":"Today’s acquisition of ArisGlobal marks a major step forward in executing that vision. By combining our leadership in…\n","protected":false},"author":2,"featured_media":9642,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13061],"tags":[13951,4664,8057,16542,2542,14224,8083],"class_list":["post-63433","post","type-post","status-publish","format-standard","has-post-thumbnail","category-dassault-systemes","tag-cloud-software","tag-dassault","tag-dassault-systemes","tag-ifrs","tag-life-sciences","tag-operating-cash-flow","tag-operating-margin"],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts\/63433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/comments?post=63433"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/posts\/63433\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/media\/9642"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/media?parent=63433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/categories?post=63433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/france\/wp-json\/wp\/v2\/tags?post=63433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
For more information, visit www.3ds.com<\/a>. <\/p>\n
Subscription revenue also includes Cloud revenue. Cloud revenue is generated from contracts that provide access to cloud-based solutions (SaaS), infrastructure as a service (IaaS), cloud solution development and cloud managed services.
Subscription revenue is also derived from cloud contracts and hybrid on-premise and cloud contracts. It also includes subscription renewals of on-premise licenses signed with hybrid on-premise and cloud deals. <\/p>\n
SUPPLEMENTAL NON-IFRS FINANCIAL INFORMATION
IFRS \u2013 NON-IFRS RECONCILIATION
(unaudited; in millions of Euros, except per share data and percentages) <\/p>\n
(3) Based on a weighted average 1,325.3 million diluted shares for Q2 2026 and 1,324.4 million diluted shares for Q2 2025, and, for IFRS only, a diluted net income attributable to the shareholders of \u20ac 297.1 million for Q2 2026 (\u20ac 223.5 million for Q2 2025). The Diluted net income attributable to equity holders of the Group corresponds to the Net Income attributable to equity holders of the Group adjusted by the impact of the share-based compensation plans to be settled either in cash or in shares at the option of the Group. <\/p>\n
SUPPLEMENTAL NON-IFRS FINANCIAL INFORMATION
IFRS \u2013 NON-IFRS RECONCILIATION
(unaudited; in millions of Euros, except per share data and percentages) <\/p>\n
(3) Based on a weighted average 1,326.1 million diluted shares for YTD 2026 and 1,325.7 million diluted shares for YTD 2025, and, for IFRS only, a diluted net income attributable to the shareholders of \u20ac 589.6 million for YTD 2026 (\u20ac 484.0 million for YTD 2025). The Diluted net income attributable to equity holders of the Group corresponds to the Net Income attributable to equity holders of the Group adjusted by the impact of the share-based compensation plans to be settled either in cash or in shares at the option of the Group. <\/p>\n